Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
23847studies shown
Showing 20,365-20,376 of 23,847
Drug study icon
CompletedNCT05520775

Semaglutide for Addiction

This summary needs review. Please check the official study record and contact the research team for details.

In Chapel Hill
AddictionDrugA study involving a medication or substance.From 21 Years to 65 Years
Countries
United States
Sponsor
University of North Carolina, Chapel Hill
Condition
Addiction
Drug study icon
CompletedNCT05891587

Semaglutide Therapy for Alcohol Reduction - Tulsa

This summary needs review. Please check the official study record and contact the research team for details.

In Tulsa
AddictionDrugOver 18 Years
Countries
United States
Sponsor
Oklahoma State University Center for Health Sciences
Condition
Addiction
Other study type icon
CompletedNCT05636033

Semantic Networks in Addiction Patients: Exploratory Study

This summary needs review. Please check the official study record and contact the research team for details.

In Paris
AddictionOtherFrom 30 Years to 60 Years
Countries
France
Sponsor
Institut National de la Santé Et de la Recherche Médicale, France
Condition
Addiction
Behavioral study icon
CompletedNCT03129204

Sensation Awareness Focused Training for Spouses

This summary needs review. Please check the official study record and contact the research team for details.

In Tampa
PTSD, Depression, ...BehavioralOver 18 Years
Countries
United States
Sponsor
University of South Florida
Condition
PTSD, Depression, ...
Other study type icon
TerminatedNCT05372523

Senseye's OBCI Diagnostic Tool for PTSD

This summary needs review. Please check the official study record and contact the research team for details.

In Sylmar
PTSDDiagnostic TestA study that looks at how to detect, measure, or better understand a condition.From 18 Years to 65 Years
Countries
United States
Sponsor
Senseye, Inc.
Condition
PTSD
Drug study icon
Enrolling By InvitationNCT05301361

Sensitivity of the NIH Toolbox to Stimulant Treatment in Intellectual Disabilities

This study is comparing Methylphenidate Oral Solution with placebo for people with Intellectual Disability, Fragile X Syndrome, Down Syndrome, or Attention Deficit Hyperactivity Disorder. Participants receive Methylphenidate Oral Solution or placebo and complete study visits and assessments.

Multiple locations, including Sacramento
ADHDDrugFrom 6 Years to 24 Years
Countries
United States
Sponsor
University of California, Davis
Condition
ADHD
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.